Quadrant Capital Group LLC Adaptive Biotechnologies Corp Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 8,876 shares of ADPT stock, worth $49,528. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,876
Previous 8,876
-0.0%
Holding current value
$49,528
Previous $32,000
40.63%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ADPT
# of Institutions
202Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$167 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$80.4 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$65.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$64.7 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$59.4 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $797M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...